Stockreport

CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF HOUSTON, Nov. 19, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("Company"), a biotechnology company specializing in the development of novel treatments [Read more]